Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
Gennaro M, De Santis MC, Mariani L, Lo Vullo S, Cappelletti V, Agresti R, Cortinovis U, Paolini B, Di Cosimo S, Carcangiu ML, Daidone MG, Lozza L. Gennaro M, et al. Among authors: agresti r. Breast. 2017 Oct;35:63-68. doi: 10.1016/j.breast.2017.06.010. Epub 2017 Jun 23. Breast. 2017. PMID: 28651115
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, Decise D, De Sanctis V, Greco M, Daidone MG, Bombardieri E. Crippa F, et al. Among authors: agresti r. Eur J Nucl Med. 1998 Oct;25(10):1429-34. doi: 10.1007/s002590050319. Eur J Nucl Med. 1998. PMID: 9818284 Clinical Trial.
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N. Greco M, et al. Among authors: agresti r. J Natl Cancer Inst. 2001 Apr 18;93(8):630-5. doi: 10.1093/jnci/93.8.630. J Natl Cancer Inst. 2001. PMID: 11309439 Clinical Trial.
Role of HER2 in wound-induced breast carcinoma proliferation.
Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Ménard S. Tagliabue E, et al. Among authors: agresti r. Lancet. 2003 Aug 16;362(9383):527-33. doi: 10.1016/S0140-6736(03)14112-8. Lancet. 2003. PMID: 12932384
Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.
Demicheli R, Ardoino I, Boracchi P, Coradini D, Agresti R, Ferraris C, Gennaro M, Hrushesky WJ, Biganzoli E. Demicheli R, et al. Among authors: agresti r. BMC Cancer. 2010 Nov 30;10:656. doi: 10.1186/1471-2407-10-656. BMC Cancer. 2010. PMID: 21118508 Free PMC article.
89 results